ImmunoGen, Inc. (IMGN) Receives Consensus Rating of "Hold" from Brokerages

ImmunoGen, Inc. (IMGN) Receives Consensus Rating of "Hold" from Brokerages


Shares of ImmunoGen, Inc. have been assigned an average rating of "Hold" from the ten brokerages that are covering the company. Two equities research analysts have rated the stock with a sell recommendation, six have assigned a hold recommendation and two have issued a buy recommendation on the company.



from Biotech News